Oncolytics Biotech News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.07.19	6 Top Losers In Healthcare Sector (LXRX, XBIO, ONCY...) (RTTNews)
18.01.18	Fiera Capital reports December 2017 preliminary assets under management (PR Newswire)
14.11.17	IIROC Trading Halt - N (PR Newswire)
14.11.17	Transat célèbre ses 30 ans - Ses avions arborent une nouvelle livrée (PR Newswire)
18.10.17	STL Le Corbusier Boulevard central stops ready for users starting October 21st (PR Newswire)
12.10.17	Important projet de recherche et de développement dans le secteur de la transformation des produits de la pêche (PR Newswire)
29.09.17	L'entreprise montréalaise Stradigi lance son laboratoire de recherche appliquée sur l'intelligence artificielle pour servir les secteurs de la santé, des sports et du social (PR Newswire)
06.04.17	ARLZ Hands Out Pink Slips, JAZZ On A High Note, STDY On Track, TENX Abuzz (RTTNews)
27.08.15	ONCY Completes Study Enrollment, LMNX Files For NxTAG Approval, ADXS On Watch (RTTNews)
19.05.15	Oncolytics To Study REOLYSIN In Combination With GM-CSF In Pediatric Patients (RTTNews)
20.04.15	ATHX Suffers Another Blow, MRK's Keytruda Proven Superior, TROV Outperforms (RTTNews)
07.04.15	Oncolytics Seeks Orphan Drug Status From FDA For REOLYSIN In Gastric Cancer (RTTNews)
25.03.15	Oncolytics: EMA Grants Orphan Drug Designation For REOLYSIN - Quick Facts (RTTNews)
03.03.15	Oncolytics Biotech Gets Orphan Drug Designation For Primary Peritoneal Cancer (RTTNews)
02.03.15	Oncolytics Gets Orphan Drug Designation From FDA For Cancer Of Fallopian Tube (RTTNews)
19.02.15	CBLI Back On Track, HTBX Joins Hands With OncoSec, PRAH In Good Health (RTTNews)
18.02.15	Eagle Soars, VBLT Crushed Over Drug Failure, Study Fails To Soothe CLTX (RTTNews)
12.02.15	ANIK Makes Regulatory Submissions, ADXS Joins Hands With INCY, IMDZ On Watch (RTTNews)
11.02.15	FDA Grants Orphan Drug Designation For Oncolytics' REOLYSIN For Ovarian Cancer (RTTNews)
11.02.15	FDA Grants Orphan Drug Designation To Oncolytics' Reolysin For Ovarian Cancer (RTTNews)
09.02.15	Oncolytics Biotech Files Orphan Drug Designation With FDA For High Grade Gliomas (RTTNews)
02.12.14	Oncolytics Files For Orphan Drug Designation For Pancreatic & Ovarian Cancers (RTTNews)
03.09.14	Oncolytics Biotech Closes Patient Enrollment In US Phase 2 Ovarian Cancer Study (RTTNews)
22.10.13	Oncolytics Reports Progression Free Survival Data For Phase 2 Study Of REOLYSIN (RTTNews)
22.10.13	Oncolytics Biotech® Inc. Announces Progression Free Survival Data for Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer (PR Newswire)
01.10.13	Oncolytics Biotech Inc. Collaborators to Present Positive Clinical Trial Data at the 15th Annual World Conference on Lung Cancer (PR Newswire)
01.10.13	Garibaldi updates program at Grizzly Property (PR Newswire)
12.09.13	Biotech Firms Receive Orphan Drug Designations, Release Clinical Data, Achieve Goals, Enter Acquisitions & Forecast Revenues - Research Report on Aegerion, Oncolytics, Merrimack, Sangamo, and PDL (PR Newswire)
10.09.13	NBIX Craters, DHRM Gets Busy, TGTX, BLRX Compounds Get Orphan Drug Status (RTTNews)
09.09.13	Media Advisory - Oncolytics Biotech® Inc. Announces Participation in Upcoming Conferences (PR Newswire)
09.09.13	Oncolytics Biotech® Inc. Announces Positive Final Tumour Response Data for U.S. Phase 2 Study of REOLYSIN® in Squamous Cell Lung Cancer (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Oncolytics Biotech Inc

Aktien Top/Flop

Meistgelesene Nachrichten